Skip to main content

Research Integrity Office

Research Integrity Office

The Research Integrity Office manages the SAMRC Research Integrity Programmes and Ethics Office.

What we offer

  • Promotion of responsible conduct of research, handling of cases of possible breach of research norms and standards, and possible research misconduct.
  • Ensuring quality assurance and data management and implement systems to ensure efficiency including meeting ethics standards by all SAMRC researchers and/or scientists.
  • Awareness creation regarding SAMRC policies and procedures, legislations, regulations and guidelines (National & International) and best practices.
  • We provide guidance and advice regarding international statements on research integrity. The office also facilitates training/education on good clinical practice and applied ethics to ensure compliance to regulatory requirements.
  • Providing operational support to the Human Research Ethics Committee and to the Ethics Committee for Research on Animals.


In order to define research integrity (RI), it is useful to summarise an article by Nick Steneck. He says that research behaviours can be put into three categories: deliberate misconduct, commonly defined as fabrication, falsification, and plagiarism (FFP); questionable research practices (QRP); and responsible conduct of research (RCR). RCR represents the ideal standard institutions and individuals endeavour to meet. FFP encompasses practices everyone agrees should be avoided. QRP fall some place in between.

RCR can be defined as conducting research in ways that fulfil the professional responsibilities of researchers, as defined by their professional organisations, the institutions for which they work and, when relevant, the government and public. The term “research integrity” refers to a characterisation or an evaluation of research behaviour. Research integrity could be defined as the quality of possessing and steadfastly adhering to high moral principles and professional standards, as outlined by professional organisations, research institutions and, when relevant, the government and public. Over the last 5 years, evidence has accumulated that appears to puts the level of occurrence for serious misconduct near 1%.

Research ethics is research behaviour viewed from the perspective of moral principles, and research integrity is research behaviour viewed from the perspective of professional standards.

Questionable research practices (QRP) include misrepresentation: researchers should honestly and accurately represent their contributions to research publications, but studies have shown that significant numbers do not; inaccuracy: research misconduct policies commonly exclude honest errors and careless mistakes; bias: research strives to bring objectivity to investigations, implying that researchers should make reasonable efforts to separate personal, subjective views from experimentally based factual information.

Fabrication, Falsification and Plagiarism (FFP)
It can be questioned how much the three presumed most serious research misbehaviours, FFP, adversely impact the research record or society. Plagiarism has no necessary impact on the reliability of the research record. It may waste some funds used to review and publish a plagiarised article, or to pay a person who may not deserve a particular position or promotion, or it can undermine trust and potentially cause some public harm, if a plagiarist is not truly an expert in some field of study and is called upon to give advice in that area. However, the extent of the impact of plagiarism on research is probably small in comparison to other irresponsible behaviours. In contrast, fabrication and falsification obviously can have significant impacts on research. A researcher who intentionally publishes fabricated or falsified research results clearly undermines the reliability of the research record and of all decisions and/or relationships based on that research. Simply based on higher levels of occurrence, QRP should have proportionally greater impacts on research than FFP. QRP probably has its greatest impact in the area of research-based, health-care decisions, e.g. new drugs, new medical devices and procedures, new treatment, etc. The growing body of research on research integrity clearly shows that the public’s investment in research is not adequately protected from irresponsible practice. Research findings also strongly suggest that the greatest public harm in terms of wasted dollars and questionable health-care decisions stems from QRP, not FFP.


  • Steneck NH. Fostering integrity in research: definitions, current knowledge, and future directions. Science and Engineering Ethics (2006) 12, 53-74
  • The Singapore Statement on Research Integrity
  • The principles and responsibilities set out in the Singapore Statement on Research Integrity represent the first international effort to encourage the development of unified policies, guidelines and codes of conduct, with the long-range goal of fostering greater integrity in research worldwide.
  • The Statement is the product of the collective effort and insights of the 340 individuals from 51 countries who participated in the 2nd World Conference on Research Integrity. These included researchers, funders, representatives of research institutions (universities and research institutes) and research publishers. The Statement was developed by a small drafting committee; discussed and commented upon before, during and after the 2nd World Conference; and then finalised for release and global use on 22 September 2010.
  • The 3rd World Conference on Research Integrity was held in Montreal, Canada, from 5-8 May 2013.
  • The Montreal Statement on Research Integrity in Cross-Boundary Research Collaborations -
  • The 4th World Conference on Research Integrity will be held in Rio de Janeiro, Brazil, from 31 May to 3 June 2015.
  • The Office of Research Integrity of the United States Dept of Health & Human Services (
  • The Office of Research Integrity (ORI) oversees and directs Public Health Service (PHS) research integrity activities on behalf of the Secretary of Health and Human Services with the exception of the regulatory research integrity activities of the Food and Drug Administration. The ORI publishes misconduct case summaries and a regular newsletter - ( They also provide information on how to handle research misconduct, forensic tools, and RCR resources. The ORI can also be followed on Twitter at @HHS_ORI.
  • The RIO has the following available as well: The Lab is an educational interactive video designed to educate viewers about responsible conduct of research (RCR) and research integrity issues. The intended audience for this study includes graduate students, postdoctoral fellows, faculty, research staff, administrators and research integrity officers (RIOs). During the course of the video: the viewer is presented with a scenario about an ethical dilemma, they must choose which perspective from which to engage the scenario (i.e. graduate student, postdoctoral fellow, principle investigator, or RIO); and they are required to make ethical decisions at key points in the storyline. The user’s ethical decisions determine how the story unfolds.
  • Research integrity at the SAMRC
    The SAMRC has a policy on research integrity, which was last updated in 2008. It needs to be revised. 
  • Here is a list of articles and webpages on research integrity.


Contact Details

Dr Seeiso Koali
Research Integrity Officer
  • +27 21 938-0393
Ms A Labuschagne
  • +27 21 938-0687
Ms Tara Langdown
Chief Officer
  • + 27 21 938 0352